Growing the love for investing
Results 1 - 10 of 63 : 1 2 3 4 5 6 7 Next
Why Seattle Genetics Shares Dropped Then Rallied
Is this meaningful or just another movement?
It's Fashionably Late, but This Biotech's Party Is Just Starting
Seattle Genetics partners with Roche to develop a companion diagnostic for Adcetris.
Here's What This Massive Money Manager Is Buying
It can be smart to keep an eye on the smart investors.
That's the question for Seattle Genetics.
Warning: Don't Sell on This News
Seattle Genetics' warning label isn't as bad as it sounds.
This mechanical strategy might cast a winning spell
What to Look For With Seattle Genetics in 2012
The launch of its new drug Adcetris will be key.
Health Care's 5 Worst November Flops
These stocks had a terrible month.
Winners and Losers of Roche's Avastin Woes
What the FDA giveth, the FDA can taketh away.
But maybe not in the long term.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK